Company Filing History:
7 out of 2,943 
1 out of 4,814 
1 out of 1,248 
Years Active: 2005-2013
Title: Matthias Grell: Innovator in Pharmaceutical Chemistry
Introduction
Matthias Grell is a prominent inventor based in Darmstadt, Germany, known for his significant contributions to the field of pharmaceutical chemistry. With a total of nine patents to his name, Grell has made remarkable advancements in the development of compounds that have therapeutic potential.
Latest Patents
Two of his latest patents highlight his innovative work. The first patent focuses on methylene urea derivatives, specifically their use as inhibitors of raf-kinase. This invention outlines a method of treatment that involves administering a pharmaceutical composition derived from these compounds to patients. The second patent pertains to hydroxyquinoline derivatives, which are identified as inhibitors of cell proliferation and have applications in tumor treatment.
Career Highlights
Throughout his career, Matthias Grell has collaborated with esteemed organizations such as Merck Patent GmbH and the Fraunhofer Society for the Advancement of Applied Research. These experiences have enriched his expertise and contributed to his prolific output of patents in the pharmaceutical domain.
Collaborations
Grell has worked alongside notable colleagues, including Hans-Peter Buchstaller and Matthias Wiesner. Their combined efforts in research and development have propelled innovation and broadened the scope of potential treatments in the medical field.
Conclusion
In summary, Matthias Grell's work as an inventor underscores the vital role of innovation in the pharmaceutical industry. His patents not only showcase his inventive spirit but also provide valuable avenues for future medical therapies and treatments.